See more : Van de Velde NV (VDEVF) Income Statement Analysis – Financial Results
Complete financial analysis of GABY Inc. (GABY.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GABY Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- JE Cleantech Holdings Limited (JCSE) Income Statement Analysis – Financial Results
- Bellatora Inc. (ECGR) Income Statement Analysis – Financial Results
- Adishakti Loha and Ispat Limit (ADISHAKTI.BO) Income Statement Analysis – Financial Results
- RESGEN LIMITED (RESGEN.BO) Income Statement Analysis – Financial Results
- CGG BSA 1 (CGGBS.PA) Income Statement Analysis – Financial Results
GABY Inc. (GABY.CN)
About GABY Inc.
GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States. The company packages and markets various cannabis products, including flowers, concentrates, pre-rolls, edibles, topicals, tinctures, and other products derived from or infused with cannabis or hemp. It offers its cannabis products under the Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space brand names. The company was formerly known as Gabriella's Kitchen Inc. and changed its name to GABY Inc. in September 2019. GABY Inc. was incorporated in 2003 and is based in Calgary, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 21.77M | 25.44M | 3.19M | 8.40M | 1.49M | 952.53K |
| Cost of Revenue | 11.69M | 16.17M | 3.31M | 9.10M | 2.19M | 1.37M |
| Gross Profit | 10.08M | 9.27M | -119.21K | -696.45K | -700.27K | -420.64K |
| Gross Profit Ratio | 46.31% | 36.44% | -3.73% | -8.29% | -46.95% | -44.16% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.02M | 8.85M | 5.65M | 9.71M | 5.52M | 2.38M |
| Selling & Marketing | 1.08M | 770.30K | 134.92K | 1.01M | 312.38K | 553.20K |
| SG&A | 10.10M | 9.62M | 5.79M | 10.72M | 5.83M | 2.94M |
| Other Expenses | 1.57M | 1.14M | 18.75K | 409.27K | 69.99K | 35.16K |
| Operating Expenses | 11.67M | 10.76M | 5.81M | 11.13M | 5.90M | 2.97M |
| Cost & Expenses | 23.36M | 26.93M | 9.12M | 20.23M | 8.09M | 4.35M |
| Interest Income | 4.24K | 1.53K | 0.00 | 2.95K | 9.74K | 64.00 |
| Interest Expense | 3.22M | 2.62M | 422.18K | 589.95K | 633.10K | 227.57K |
| Depreciation & Amortization | 1.72M | 1.40M | 621.11K | 2.25M | 185.69K | 147.59K |
| EBITDA | 128.03K | -86.06K | -7.36M | -12.93M | -6.41M | -3.43M |
| EBITDA Ratio | 0.59% | -0.39% | -172.66% | -114.03% | -462.71% | -355.38% |
| Operating Income | -1.59M | -1.50M | -6.13M | -11.83M | -6.60M | -3.39M |
| Operating Income Ratio | -7.29% | -5.90% | -192.11% | -140.76% | -442.35% | -356.16% |
| Total Other Income/Expenses | -26.02M | -6.28M | -4.17M | -5.87M | -1.12M | -367.75K |
| Income Before Tax | -27.61M | -7.67M | -10.30M | -17.70M | -7.72M | -3.76M |
| Income Before Tax Ratio | -126.81% | -30.17% | -322.67% | -210.61% | -517.60% | -394.77% |
| Income Tax Expense | 1.65M | 1.93M | -242.24K | -250.62K | -489.33K | -140.18K |
| Net Income | -29.25M | -9.61M | -10.06M | -17.45M | -7.72M | -3.76M |
| Net Income Ratio | -134.36% | -37.76% | -315.09% | -207.63% | -517.60% | -394.77% |
| EPS | -0.04 | -0.02 | -0.04 | -0.12 | -0.12 | -0.04 |
| EPS Diluted | -0.04 | -0.02 | -0.04 | -0.12 | -0.12 | -0.04 |
| Weighted Avg Shares Out | 706.50M | 539.48M | 228.94M | 144.56M | 65.16M | 88.52M |
| Weighted Avg Shares Out (Dil) | 706.50M | 539.48M | 228.94M | 144.56M | 65.16M | 88.56M |
Source: https://incomestatements.info
Category: Stock Reports